Successful treatment of a NSCLC patient harbouring an EGFR mutation and a concomitant Met Exon 14 skipping mutation combining afatinib and crizotinib
Kauffmann-Guerrero, Diego, Kahnert, Kathrin, Kumbrink, Jörg, Syunyaeva, Zulfiya, Tufman, Amanda, Huber, Rudolf M.Language:
english
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2018.09.009
Date:
September, 2018
File:
PDF, 6.95 MB
english, 2018